<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1179">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05145803</url>
  </required_header>
  <id_info>
    <org_study_id>21-2823</org_study_id>
    <nct_id>NCT05145803</nct_id>
  </id_info>
  <brief_title>ASYMPTOMATIC AND PRE-SYMPTOMATIC TRANSMISSION OF SARS-COV-2 IN A COMMUNITY CONGREGANT SETTING</brief_title>
  <official_title>ASYMPTOMATIC AND PRE-SYMPTOMATIC TRANSMISSION OF SARS-COV-2 IN A COMMUNITY CONGREGANT SETTING: A STUDY TO UNDERSTAND HOW INFECTION CONTROL PRACTICES CAN MITIGATE EXPOSURE RISKS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Colorado School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Colorado State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Boulder</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Colorado Mesa University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regis University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Denver Health Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Colorado Springs</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Colorado School of Public Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall aim of this study is to measure how transmission of COVID-19 occurs in&#xD;
      communities - including the role of super spreaders and/or identifying conditions that may&#xD;
      increase transmission risk, with a focus on congregant situations. In order to identify how&#xD;
      presence of symptoms and behavior affects the transmissibility of the virus, we will measure&#xD;
      SARS-CoV-2 in exhaled breath of asymptomatic and symptomatic persons using polyvinyl alcohol&#xD;
      (PVA) test strips embedded in face masks (Face Mask Sampling- &quot;FMS&quot;) - an innovative,&#xD;
      non-invasive method for detection of SARS-CoV-2 in exhaled air.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 9, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>PVA strip positivity</measure>
    <time_frame>72 hours after sample collection</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3300</enrollment>
  <condition>COVID-19</condition>
  <condition>SARS-CoV2 Infection</condition>
  <arm_group>
    <arm_group_label>College Students</arm_group_label>
    <description>Collegiate students tested positive for SARS-CoV-2 by a molecular reference test (PCR test or antigen test) (index patients).&#xD;
Collegiate students known to be contacts of the index patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Polyvinylalcohol strip [diagnostic]</intervention_name>
    <description>We will measure SARS-CoV-2 in exhaled breath of asymptomatic and symptomatic persons using PVA test strips embedded in face masks (FMS) -an innovative, non-invasive method for detection of SARS-CoV-2 in exhaled air. Utilizing this approach, our study aims to utilize the test results extracted from the masks to identify risk factors for SARS-CoV-2 transmission and timing of infectious period in exposed people (pre-symptomatic, asymptomatic, and symptomatic).</description>
    <arm_group_label>College Students</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Nasal swabs, PVA in masks, venous blood sample [1x], dried blood spots [optional]&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Students 18 years and older&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals age ≥ 18 years of any gender tested positive for SARS-CoV-2 by a molecular&#xD;
             reference test (PCR test or antigen test) [INDEX PATIENTS]&#xD;
&#xD;
          -  Individuals age ≥ 18 years and known to be contacts of the index patients [CONTACTS]&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt; age 18 years old, unable to wear a face mask due to underlying condition, not able&#xD;
             to consent, pregnancy. In addition, signs of severe disease present at time of&#xD;
             enrollment (e.g. difficulty breathing, pain when breathing, tightness of chest or&#xD;
             developing irregular heart beat).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Geoffrey Winstanley, PharmD</last_name>
    <role>Study Director</role>
    <affiliation>Colorado School of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Molly Lamb, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Colorado School of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>May Chu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Colorado School of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Jaenisch, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Colorado School of Public Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Jaenisch, MD, PhD</last_name>
    <phone>720-626-1094</phone>
    <email>thomas.jaenisch@cuanschutz.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>May Chu, PhD</last_name>
    <email>may.chu@cuanschutz.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Montague, DO</last_name>
      <email>Brian.Montague@cuanschutz.edu</email>
    </contact>
    <investigator>
      <last_name>Brian Montague, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado, Boulder</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leisha Conners Bauer, MPA</last_name>
      <email>Leisha.ConnersBauer@Colorado.EDU</email>
    </contact>
    <investigator>
      <last_name>Leisha Conners Bauer, MPA</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gloria Brisson, MSN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado, Colorado Springs</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80918</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Hanenberg, MSN</last_name>
      <phone>719-255-4444</phone>
      <email>shanenbe@uccs.edu</email>
    </contact>
    <investigator>
      <last_name>Stephanie Hanenberg, MSN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Denver Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kellie Hawkins, MD</last_name>
      <email>Kellie.Hawkins@dhha.org</email>
    </contact>
    <investigator>
      <last_name>Kellie Hawkins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regis University</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie James, PhD</last_name>
      <email>sjames001@regis.edu</email>
    </contact>
    <investigator>
      <last_name>Stephanie James, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colorado State University</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80523</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeannine Riess</last_name>
      <phone>970-491-6121</phone>
    </contact>
    <investigator>
      <last_name>Joni T van Sickle, BS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeannine Riess, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 1, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Colorado School of Public Health</investigator_affiliation>
    <investigator_full_name>Thomas Jaenisch</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>COVID-19 Transmission</keyword>
  <keyword>SARS-CoV2 Transmission</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

